Oct 13, 2021

Huntsman Cancer Institute Researcher Receives Grant to Study Pediatric Proton Therapy

Huntsman Cancer Institute physician and researcher Matthew Poppe, MD, received a National Cancer Institute grant to study side effects of different types of radiation—proton therapy and traditional radiation therapy—in the treatment of pediatric patients.

Sep 13, 2021

Pediatric Proton Therapy: What to Expect

If your child needs proton therapy to treat cancer, you may wonder what that means. Learn what proton therapy is and what to expect as your child goes through pediatric proton therapy treatment.

Aug 19, 2021

New Research Identifies Genomic Markers of Aggressive Childhood Leukemias

New research published today in JAMA Oncology reports how two separate DNA changes appear to predict aggressive childhood leukemias when they occur in combination. This study illuminates genetic understanding of acute lymphoblastic leukemia in children with the worst outcomes, including relapse and/or death.

Jun 23, 2021

Proton Therapy Opens in Utah

Patients, doctors, scientists, donors, and community members gathered on June 23, 2021 to mark the opening of a major new resource for cancer care in Utah. The Senator Orrin G. Hatch Proton Therapy Center at Huntsman Cancer Institute (HCI) is the first of its kind in the Mountain West and one of only 37 such centers nationwide.

Mar 03, 2021

Utah Researchers Illuminate Potential Precursors of Blood Cancers

Utah researchers report significant new insights into the development of blood cancers. Comparing DNA data in people with and without blood disorders, the researchers discovered genetic mutations in about 2% of the presumably healthy participants that were identical to those frequently observed in the cancer patients. These findings provide new clues about mutations that may initiate cancer development and those that may help cancer progress.

Oct 20, 2020

Talks with Docs: Samuel Cheshier, Pediatric Neurosurgeon

“I just love taking care of them, helping make them better,” says pediatric neurosurgeon Samuel Cheshier about the children he treats at Huntsman Cancer Institute and Primary Children’s Hospital. He talks about what he has learned from these kids and their parents, what patients should know about Huntsman Cancer Institute, and what he reads about in his spare time.

Oct 16, 2020

Fighting Brain Tumors in Kids

When Samuel Cheshier was 13 years old, his favorite cousin died of colon cancer. “I always think of him when I do cancer research,” Cheshier says. As a pediatric neurosurgeon, he witnesses firsthand the devastation that malignant brain tumors cause patients and their families. The desire to help them motivates his basic science research, with the goal of translating experiments into therapies. The 5 for the Fight Fellowship will help speed up the pace of his research, allowing him to start a new project.

Sep 29, 2020

5 For The Fight Announces Inaugural Class of Cancer Research Fellows at Huntsman Cancer Institute

5 For The Fight, a global movement inviting everyone to give $5 for the fight against cancer, today announced the inaugural recipients of the 5 For The Fight Cancer Research Fellowship in partnership with Huntsman Cancer Institute at the University of Utah.

Sep 25, 2020

This Childhood Cancer Patient Is One Tough Princess

Holly was six years old when she was diagnosed with Ewing sarcoma. Her treatment involved 39 radiation treatments at Huntsman Cancer Institute and 14 rounds of chemotherapy at Primary Children’s Hospital. All the while, Holly found ways to feel strong. She became an expert hand washer in order to help her immune system. She learned to take care of her own port. She weighed in on decisions about her treatment options.

Sep 18, 2020

Committed to a Positive and Lasting Impact: The Engelstad Foundation

Samuel Cheshier, MD, PhD, and the Neurologic Cancers Center team at Huntsman Cancer Institute are working to find better treatments for brain cancer, particularly pediatric brain cancer. Many primary brain tumors are incurable from the start, and currently, none are curable once they recur. The need for novel, effective therapies is critical. In 2020, the Engelstad Foundation funded a $100,000 grant at HCI to study a potential immunotherapy treatment for pediatric brain tumors.

Aug 21, 2020

Huntsman Cancer Institute Researchers Receive Grants from St. Baldrick’s Foundation Amid Pandemic

Two researchers at Huntsman Cancer Institute at the University of Utah received awards from the St. Baldrick’s Foundation to fund innovative childhood cancer research.

May 07, 2020

Proton Accelerator Arrives at Huntsman Cancer Institute

Construction at the Senator Orrin G. Hatch Proton Therapy Center at Huntsman Cancer Institute is well underway. On March 28, a 15-ton proton accelerator arrived and was installed at the future center. This marks a major milestone for the project slated for a December 2020 debut.

Apr 10, 2020

One Sibling’s Perspective on Childhood Cancer

When a child is diagnosed with any life-threatening disease, especially cancer, the focus shifts to the child suffering from that disease—as it should. But what is often forgotten is how the entire family is affected. Understandably, we often think of primary caregivers, in most cases the parents. Very rarely do we hear a sibling’s perspective, like mine.

Mar 01, 2020

El aire aparente: contaminación, cáncer y salud

A pesar de su impresionante belleza montañosa, Salt Lake City viene con la compensación de un aire pobre periódico. En el informe "Salud del aire" de 2019 del American Thoracic Society, Salt Lake se clasificó en el puesto 23 entre las ciudades estadounidenses con mayor impacto en la salud debido a la calidad del aire. Entre los más vulnerables están los ancianos y los niños.

Mar 01, 2020

The Air Apparent: Pollution, Cancer, and Health

For all of its breathtaking mountainous beauty, Salt Lake City comes with the tradeoff of periodic poor air. In the 2019 “Health of the Air” report by the American Thoracic Society, Salt Lake ranked 23rd among U.S. cities with the highest health impacts due to air quality. Among those most vulnerable are the elderly and children.

Mar 12, 2019

Huntsman Translational Scholars: Matthew Poppe, MD

Huntsman Cancer Institute (HCI) has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Translational researchers extend basic discoveries made in the laboratory and apply them to solve clinical problems and benefit patients through new diagnostic and therapeutic approaches.

Mar 01, 2019

Breaking Ground for Proton Therapy

When construction is complete in 2021, Huntsman Cancer Institute will implement the latest advance in proton therapy, called intensity-modulated proton therapy. Proton therapy is the favored approach for many tumors in and around vital structures such as the spinal cord and brain stem. It is also the preferred treatment for certain childhood cancers. We are committed to bringing cutting-edge care to our patients, and proton therapy will be the next step in that promise.

Oct 11, 2018

Study Holds Promise for New Pediatric Brain Tumor Treatment

New research published in Nature Communications from scientists at Huntsman Cancer Institute at the University of Utah, in collaboration with the Stanford University School of Medicine, shows a specific protein regulates both the initiation of cancer spreading and the self-renewal of cancer cells in medulloblastoma, a type of pediatric brain cancer.

Feb 15, 2018

Building onto a Dream: The Primary Children's and Families' Cancer Research Center

Huntsman Cancer Institute began in 1995 with an empty lot and a dream full of promise. Twenty-two years later, HCI opened a major expansion that doubled its research capacity.

Oct 27, 2016

Promise of Better Targeted Treatments Now Possible in Children’s Brain Cancer

SALT LAKE CITY—More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer. Writing this week in the journal Cell Reports, researchers at Huntsman Cancer Institute (HCI) at the University of Utah report they have identified an existing group of drugs that appear to reduce or eliminate a certain subgroup of childhood brain cancers while sparing normal brain tissue. The research was conducted using a new zebrafish animal model system developed by the researchers, which closely resembles an aggressive subtype of pediatric brain tumors.

Apr 21, 2015

Study Finds Childhood Cancer Survivors More Likely to Be Enrolled in Social Security Support as Adults

Children with cancer have a good chance of surviving the disease—today more than 80% survive due to advances in treatment and care. However, recent studies have shown that some of these more than 420,000 U.S. childhood cancer survivors face future health related challenges as they become adults such as a second cancer diagnosis, cardiac failure, or other severe medical complications.